Nurtec ODT 75 MG tablet 8S
Ended Awarded
- Contract number
- SPE2DB25FQ89C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $62,354
Award facts
- Contract value 100% obligated
- $62,353.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $62,353.92 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a firm fixed-price contract with no set-aside designation, competitively awarded on September 24, 2025, with an ultimate completion date of September 25, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement needs. The company's portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen's extensive supply of neurological and pain management pharmaceuticals to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The non-set-aside competitive award reflects the company's established capability to meet federal procurement requirements and maintain continuity of essential pharmaceutical supply to military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FQ89C?
SPE2DB25FQ89C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FQ89C worth?
The government has obligated $62,354 on SPE2DB25FQ89C.
Is contract SPE2DB25FQ89C an order under another contract?
Yes. SPE2DB25FQ89C is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ89C competed?
The extent of competition for SPE2DB25FQ89C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award